Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-23-100077

Options or other derivatives

  • Chief Financial Officer acquired 253,123 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

O'Loughlin Steve · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +253,123 253,123 D
Loading xslF345X05/ownership.xml…